Nanomedicine-Mediated Optimization of Immunotherapeutic Approaches in Cervical Cancer

Abstract

Cervical cancer shows immense complexity at the epigenetic, genetic and cellular levels, limiting conventional treatment. Immunotherapy has revolutionized nanomedicine and rejuvenated the field of tumor immunology. Although several immunotherapeutic approaches have shown favorable clinical responses, their efficacies vary, with subsets of patients benefitting. The success of cancer immunotherapy requires the enhancement of cytokines and antitumor effector cell production and activation. Recently, the feasibility of nanoparticle-based cytokine approaches in tumor immunotherapy has been highlighted. Immunotherapeutic nanoparticle-based platforms form a novel strategy enabling researchers to co-deliver immunomodulatory agents, target tumors, improve pharmacokinetics and minimize collateral toxicity to healthy cells. This review looks at the potential of immunotherapy and nanotechnologically enhanced immunotherapeutic approaches for cervical cancer.

Nanomedicine for Neurodegenerative Disorders: Focus on Alzheimer’s and Parkinson’s Diseases

“…This malleability of nanoparticles (NPs) allows for the attachment of various biomolecules, thereby allowing for the efficient and safe transportation of pharmacologically active agents, such as genes or drugs. NP delivery vehicles of 1-100 nm in size have the ability to penetrate significant physiological barriers such as those found in the lungs, liver, gastrointestinal fluid, blood, tumour vasculature, mucosal membranes, and the blood-brain barrier [57][58][59]. Various NPs have been utilized in this regard, each portraying their unique characteristics as a therapeutic, diagnostic or theranostic tool.…”

Targeting the ACE2 receptor using nanomedicine: Novel approach to lung cancer therapy

“…One of the most popular uses of NPs is as de-livery vehicles for therapeutic agents to tumour sites. NPs less than 100 nm in size have the ability to penetrate physiological barriers, including those found in the lung, blood, nervous system, and tumour vasculature [39] . Thus, the development of nanodelivery systems can potentially improve cancer therapy and overcome challenges faced by conventional treatments such as chemotherapy and radiation therapy.…”

Lipid Nanoparticles: Promising Treatment Approach for Parkinson’s Disease

“…The principal use of NPs is to overcome challenges faced by commonly used drugs, such as poor stability, potential immunogenicity, solubility, and reduced plasma half-life [ 37 ]. Nanodelivery systems can increase the therapeutics circulation time, allow several different administration routes, circumvent potential solubility issues using hydrophobic molecules, and cater for favorable biodistribution of the therapeutic gene or drug [ 38 ]. Overall, their ideal size, quantum properties, ability to be conjugated to pharmacologically active agents, and favorable surface-to-mass ratio assures their potential as therapeutic delivery systems [ 39 ].…”

“…Overall, their ideal size, quantum properties, ability to be conjugated to pharmacologically active agents, and favorable surface-to-mass ratio assures their potential as therapeutic delivery systems [ 39 ]. Nanoscale particles (<100 nm) favor the passage through biological barriers, such as those found in the nervous system, lung, and vasculature surrounding tumors [ 38 , 40 ]. Nanomaterials have shown the ability to facilitate the stability and protection of genetic materials such as DNA, mRNA, and siRNA and to enhance transfection efficacy with low cytotoxicity [ 41 , 42 , 43 ].…”